Brain excitability in children with benign focal epilepsies
Cortical excitability in children with benign focal epilepsies: Transcranial Magnetic Stimulation and EEG study
Clinical Professor Soumya Ghosh
80 participants
Jan 1, 2016
Observational
Conditions
Summary
Benign Focal Epilepsy of Childhood (BFEC) is the most common type of partial motor epilepsy in the school aged child. BFEC is diagnosed based on clinical features and characteristic abnormalities on their Electroencephalogram (EEG). The frequency of seizures in BFEC is quite low and long term prognosis is generally good. Most children may not require anti-epileptic drugs (AEDs) to treat seizures. However the course may be complicated by language and cognitive impairment, by frequent or severe seizures, Todd's paresis and even status epilepticus. Inspite of being one of the most frequent epilepsies, the underlying brain abnormalities remain poorly understood. Transcranial magnetic stimulation (TMS) evaluates brain excitability in a safe, non-invasive manner. TMS may help predict the clinical severity, requirement and response to AEDs, and identify those likely to have language and cognitive impairment. BFEC is postulated to be a genetic epilepsy with possible multifactorial influence. Identical epileptiform features on EEG may be found in siblings and first degree relatives of affected children. It is not clear why some children in the family have seizures and others do not - study of brain excitability may help answer these questions. Epileptiform abnormalities similar to that in BFEC are also sometimes noted incidentally in EEGs of normal children. In this project we plan to use TMS to study children with BFEC, their unaffected siblings and parents using TMS and EEG. Abnormalities in brain excitability will be correlated with clinical features (including frequency and severity of seizures), requirement and response to AEDs, and abnormality in neurological development. This may allow us to use TMS to prognosticate whether asymptomatic children will develop seizures, which children will require treatment, which AEDs to use, and those likely to need monitoring of brain function (e.g. language).
Eligibility
Plain Language Summary
Simplified for easier understanding
This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Children with Benign Focal Epilepsy of Childhood (BFEC), children with the BFEC trait (those with abnormal EEGs characteristic of BFEC but no history of seizures), unaffected siblings and parents of children with BFEC. Transcranial magnetic stimulation will be used to assess cortical excitability. All participants will have TMS studies undertaken at enrolment. Children with BFEC or the EEG trait will have additional TMS studies undertaken at 6 months and 12 months after enrolment. Single or paired TMS pulses will be delivered to the right and left hemisphere and motor evoked potentials (MEPs) will be recorded in 2 of the following muscles of each hand: 1st dorsal interosseus, abductor pollicis brevis and abductor digiti minimi muscles. Surface emg electrodes (stick ons) will be used to record MEPs. The following measures of cortical excitation and inhibition will be recorded: 1. Resting motor threshold (RMT) 2. Stimulus amplitude to evoke an average MEP of 1mV 3. Recruitment curve (MEPs at varying stimulus intensity) 4. Intracortical excitation or facilitation (ICF) using paired pulse stimuli 5. Intracortical inhibition, short and long latency (SICI, LICI), using paired pulse stimulation 6. Late intracortical dysinhibition (LICD) using paired pulse stimulation 7. Ipsilateral silent period The duration of the TMS study will be about 1 hour All participants will have an Electro-encephalogram (EEG) recorded at enrolment as per standard PMH clinical protocol. Children with BFEC or EEG trait will have additional EEGs recorded at 6 months and 12 months after recruitment.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12616000633482